AUTHORS

Real Money authors - Chris Versace

Chris Versace

Christopher (Chris) Versace is the Chief Investment Officer at Tematica Research, which utilizes a thematic investing strategy leveraging changing economics, demographics, psychographics, technology and more to determine investment candidates, while also sidestepping companies vulnerable to thematic change. Versace also co-manages TheStreet’s Trifecta Stocks as well as Stocks Under $10, co-hosts the Cocktail Investing Podcast and developed the NJCU New Jersey 50 Index at NJCU, where he is an Assistant Professor of Finance.

Email Chris Versace

Recent Articles By The Author

Sobering Comments From Cummins

From Cummins :  "Demand accelerated in the first quarter, as the global economy continued to improve, driving strong sales growth across most businesses and regions and resulting in solid profitability. The strength and breadth of the rebound in dem...

Now About That Dividend Cut...

When Apollo Global Management holds its earnings call here on Tuesday at 8:30 a.m. ET, we can bet one hot topic will be the quarterly dividend cut it announced this morning to $0.50 per share from the prior $0.60 even though the company beat March q...

Grocery Falls Out of Favor at Goldman

Here on Tuesday morning Goldman Sachs downgraded Albertsons to Neutral from Buy with a new price target of $20 while Kroger was slapped with a new Sell rating vs. the prior Neutral with a target of $31.  This isn't surprising, as the thinking is tha...

Under Armour Overdelivers

Maybe it's me, but it seems folks are starting to get off the couch and either update their pandemic athleisure wardrobes or are starting to shed those pandemic pounds in time for the 2021 swimsuit season.  Under Armour upped its 2021 guidance here ...

More Rising Input Costs

We can add Dupont to the list of companies citing rising input costs: "We also expect similar top-line trends continuing from first quarter into the second quarter coupled with slight escalation in raw materials and logistics costs." Now to see if t...

CVS Ups Earnings Guidance

CVS Health has upped its full-year 2021 GAAP diluted EPS guidance range to $6.24-$6.36 from $6.06 to $6.22 and its full-year 2021 Adjusted EPS guidance to $7.56 -$7.68 from $7.39- $7.55 and confirmed its full-year 2021 cash flow from operations guid...

All Aboard the Earnings Ship

Good morning folks, we've got a full day of earnings reports as well as a modicum of economic data on tap. I'll be your cruise director today, and yes, that is a slight nod to The Love Boat, which ran from 1976-1985. Some of the earnings reports I'l...

Tuesday on Real Money Pro

Hungry for Dividends? Let's See What Might Crop Up in the 'Ag' Sector

Here's why good yields can be found in equipment that helps farmers produce ... good yields.

Email sent

Thank you, your email to has been sent successfully.

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight